Insmed Inc. | Large-cap | Healthcare
$105.90
0.46%
| Insmed Stock Comparison:
Insmed vs VertexInsmed vs RegeneronInsmed vs AlnylamInsmed vs Royalty Pharma plcInsmed vs IncyteInsmed vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 363.7M
Gross Profit 278.0M 76.43%
Operating Income -786.6M -216.26%
Net Income -913.8M -251.24%

Balance Sheet Metrics

Total Assets 2.0B
Total Liabilities 1.7B
Shareholders Equity 285.4M
Debt to Equity 6.10

Cash Flow Metrics

Operating Cash Flow -695.4M
Free Cash Flow -705.8M

Revenue & Profitability Trend

Insmed Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 363.7M 305.2M 245.4M 188.5M 164.4M
Cost of Goods Sold 85.7M 65.6M 55.1M 44.2M 39.9M
Gross Profit 278.0M 239.6M 190.2M 144.3M 124.5M
Operating Expenses 1.1B 915.5M 663.3M 507.0M 384.8M
Operating Income -786.6M -680.9M -478.1M -367.8M -265.2M
Pre-tax Income -910.1M -747.0M -480.2M -436.4M -292.7M
Income Tax 3.7M 2.6M 1.4M -1.8M 1.4M
Net Income -913.8M -749.6M -481.5M -434.7M -294.1M
EPS (Diluted) - -$5.34 -$3.91 -$3.88 -$3.01

Income Statement Trend

Insmed Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 1.6B 929.1M 1.3B 837.0M 622.9M
Non-Current Assets 403.6M 400.8M 383.1M 406.5M 173.3M
Total Assets 2.0B 1.3B 1.7B 1.2B 796.2M
Liabilities
Current Liabilities 297.5M 225.6M 190.2M 135.2M 118.8M
Non-Current Liabilities 1.4B 1.4B 1.4B 697.9M 401.5M
Total Liabilities 1.7B 1.7B 1.6B 833.0M 520.3M
Equity
Total Shareholders Equity 285.4M -331.9M 88.0M 410.5M 275.9M

Balance Sheet Composition

Insmed Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -913.8M -749.6M -481.5M -434.7M -294.1M
Operating Cash Flow -695.4M -544.0M -454.5M -370.9M -216.2M
Investing Activities
Capital Expenditures -21.9M -13.3M -9.9M -7.3M -6.2M
Investing Cash Flow -583.2M -223.6M -34.6M -64.3M -6.2M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 1.2B 150.0M 773.8M 590.5M 244.9M
Free Cash Flow -705.8M -549.5M -410.3M -370.6M -226.2M

Cash Flow Trend

Insmed Key Financial Ratios

Valuation Ratios

Forward P/E -24.92
Price to Book 193.43
Price to Sales 52.55
PEG Ratio -24.92

Profitability Ratios

Profit Margin -265.93%
Operating Margin -247.61%
Return on Equity -320.20%
Return on Assets -36.25%

Financial Health

Current Ratio 5.86
Debt to Equity 1,316.96
Beta 0.79

Per Share Data

EPS (TTM) -$5.93
Book Value per Share $0.55
Revenue per Share $2.21

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
insm 20.0B - 193.43 -320.20% -265.93% 1,316.96
Vertex 117.0B 32.82 7.09 -5.64% -8.91% 10.00
Regeneron 55.3B 13.02 1.84 15.96% 31.94% 9.20
Alnylam 40.8B - 353.42 -414.62% -11.49% 2,358.26
Royalty Pharma plc 20.3B 14.75 2.30 18.00% 48.26% 77.82
Incyte 13.0B 336.30 3.55 0.47% 0.48% 1.18

Financial data is updated regularly. All figures are in the company's reporting currency.